Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    SEC Filings

    SEC Filings

    Filing date Form Description View
    06-30-2021 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-21-000106.pdf
    0001401914-21-000106.xls
    06-24-2021 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-21-000088.pdf
    0001401914-21-000088.xls
    06-24-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000090.pdf
    0001401914-21-000090.xls
    06-24-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000092.pdf
    0001401914-21-000092.xls
    06-24-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000094.pdf
    0001401914-21-000094.xls
    06-24-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000098.pdf
    0001401914-21-000098.xls
    06-24-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000101.pdf
    0001401914-21-000101.xls
    06-24-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000103.pdf
    0001401914-21-000103.xls
    05-17-2021 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-21-000085.pdf
    0001401914-21-000085.xls
    05-14-2021 DEF 14A

    Official notification to shareholders of matters to be brought to a vote ("Proxy")

    View HTML
    0001401914-21-000081.pdf
    0001401914-21-000081.xls

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • …
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12
    • …
    • Next page Next ›
    • Last page Last »

    Data provided by Kaleidoscope.

    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top